INDP icon

Indaptus Therapeutics
INDP

6 hedge funds and large institutions have $129K invested in Indaptus Therapeutics in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$83.7K
2
+$57.9K
3
+$5.78K
4
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC)
Nebraska
+$4

Top Sellers

1
-$84.4K
2
-$2.7K
3
-$73
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$71K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$49.2K
Morgan Stanley
3
Morgan Stanley
New York
$4.91K
TRCT
4
Tower Research Capital (TRC)
New York
$3.44K
SS
5
SBI Securities
Japan
$31
Carson Wealth (CWM LLC)
6
Carson Wealth (CWM LLC)
Nebraska
$4
UBS Group
7
UBS Group
Switzerland
–
Bank of America
8
Bank of America
North Carolina
–